Q3 FY2026 · ended Sep 30, 2026 · Revenue $55.70M, +14.5% YoY · Filed Nov 3, 2026
Si-Bone, Inc. (SIBN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $55.7 million and a net loss of $3.6 million. Free cash flow was -$427,000. As of Sep 30, 2026 it held $35.3 million in cash and investments and $42.8 million in total debt.
Revenue
$55.70M
+14.5% vs year-ago quarter
Net income
$-3.62M
+20.7% vs year-ago quarter
Operating cash flow
$5.94M
+154.4% vs year-ago quarter
Free cash flow
$-427,000
+31.1% vs year-ago quarter
EPS
$-0.08
+27.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
45.11M
+4.0% vs year-ago quarter
Net cash
$-7.49M
Q3 FY2026
Operating margin
-7.6%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SIBN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1459839
- Former names
- SI-Bone Inc. (until Sep 30, 2011)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $55.7M | $56.0M | $52.6M | $56.3M | $48.7M |
| Operating income | -$4.4M | -$4.8M | -$5.1M | -$2.5M | -$5.4M |
| Net income | -$3.6M | -$4.1M | -$4.3M | -$1.6M | -$4.6M |
| Diluted EPS | -$0.08 | -$0.09 | -$0.10 | -$0.04 | -$0.11 |
| Operating cash flow | $5.9M | $777,000 | -$2.4M | $1.7M | $2.3M |
| Free cash flow | -$427,000 | -$768,000 | -$3.4M | $440,000 | -$620,000 |
| Total assets | $256.8M | $248.8M | $242.7M | $238.6M | $234.3M |
| Total liabilities | $72.1M | $66.4M | $63.8M | $61.0M | $62.1M |
| Stockholders' equity | $184.7M | $182.3M | $178.9M | $177.5M | $172.1M |
| Cash and investments | $35.3M | $33.1M | $33.5M | $42.2M | $26.5M |
| Total debt | $42.8M | $42.8M | $42.9M | $36.7M | $36.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Sep 11, 2026 | Aug 21, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement, New debt, Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
All 782 Si-Bone, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.